These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 23518465

  • 1. Oxford classification of immunoglobulin A nephropathy: an update.
    Roberts IS.
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):281-6. PubMed ID: 23518465
    [Abstract] [Full Text] [Related]

  • 2. Validation of the Oxford classification of IgA nephropathy.
    Herzenberg AM, Fogo AB, Reich HN, Troyanov S, Bavbek N, Massat AE, Hunley TE, Hladunewich MA, Julian BA, Fervenza FC, Cattran DC.
    Kidney Int; 2011 Aug; 80(3):310-7. PubMed ID: 21544062
    [Abstract] [Full Text] [Related]

  • 3. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.
    Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J, IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology SocietyHospital Británico de Buenos Aires, Argentina., Conference Participants.
    Kidney Int; 2017 May; 91(5):1014-1021. PubMed ID: 28341274
    [Abstract] [Full Text] [Related]

  • 4. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments.
    Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J, Roberts IS, Morando L, Camilla R, Tesar V, Lunberg S, Gesualdo L, Emma F, Rollino C, Amore A, Praga M, Feriozzi S, Segoloni G, Pani A, Cancarini G, Durlik M, Moggia E, Mazzucco G, Giannakakis C, Honsova E, Sundelin BB, Di Palma AM, Ferrario F, Gutierrez E, Asunis AM, Barratt J, Tardanico R, Perkowska-Ptasinska A, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989
    [Abstract] [Full Text] [Related]

  • 5. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort.
    Bellur SS, Roberts ISD, Troyanov S, Royal V, Coppo R, Cook HT, Cattran D, Arce Terroba Y, Asunis AM, Bajema I, Bertoni E, Bruijn JA, Cannata-Ortiz P, Casartelli D, Maria Di Palma A, Ferrario F, Fortunato M, Furci L, Gakiopoulou H, Galesic Ljubanovic D, Giannakakis K, Gomà M, Gröne HJ, Gutiérrez E, Asma Haider S, Honsova E, Ioachim E, Karkoszka H, Kipgen D, Maldyk J, Mazzucco G, Orhan D, Ozluk Y, Pantzaki A, Perkowska-Ptasinska A, Riispere Z, Soderberg MP, Steenbergen E, Stoppacciaro A, Sundelin Von Feilitzen B, Tardanico R.
    Nephrol Dial Transplant; 2019 Oct 01; 34(10):1681-1690. PubMed ID: 30561721
    [Abstract] [Full Text] [Related]

  • 6. Validity of the Oxford classification of IgA nephropathy in children.
    Shima Y, Nakanishi K, Hama T, Mukaiyama H, Togawa H, Hashimura Y, Kaito H, Sako M, Iijima K, Yoshikawa N.
    Pediatr Nephrol; 2012 May 01; 27(5):783-92. PubMed ID: 22134880
    [Abstract] [Full Text] [Related]

  • 7. Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis.
    Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Li Y.
    J Nephrol; 2018 Apr 01; 31(2):279-286. PubMed ID: 29185209
    [Abstract] [Full Text] [Related]

  • 8. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification).
    Edström Halling S, Söderberg MP, Berg UB.
    Nephrol Dial Transplant; 2012 Feb 01; 27(2):715-22. PubMed ID: 21750154
    [Abstract] [Full Text] [Related]

  • 9. IgA nephropathy: an update.
    Soares MF, Roberts IS.
    Curr Opin Nephrol Hypertens; 2017 May 01; 26(3):165-171. PubMed ID: 28221174
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
    Lv J, Shi S, Xu D, Zhang H, Troyanov S, Cattran DC, Wang H.
    Am J Kidney Dis; 2013 Nov 01; 62(5):891-9. PubMed ID: 23820066
    [Abstract] [Full Text] [Related]

  • 11. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
    Mizerska-Wasiak M, Małdyk J, Rybi-Szumińska A, Wasilewska A, Miklaszewska M, Pietrzyk J, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Pukajło-Marczyk A, Zwolińska D, Szczepańska M, Turczyn A, Roszkowska-Blaim M.
    Pediatr Nephrol; 2015 Jul 01; 30(7):1113-20. PubMed ID: 25549975
    [Abstract] [Full Text] [Related]

  • 12. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
    Wu H, Xia Z, Gao C, Zhang P, Yang X, Wang R, Wang M, Peng Y.
    BMC Nephrol; 2020 Jul 01; 21(1):247. PubMed ID: 32611399
    [Abstract] [Full Text] [Related]

  • 13. The use of the Oxford classification of IgA nephropathy to predict renal survival.
    Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C.
    Clin J Am Soc Nephrol; 2011 Oct 01; 6(10):2384-8. PubMed ID: 21885791
    [Abstract] [Full Text] [Related]

  • 14. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us?
    Haas M.
    Kidney Int; 2024 Jun 01; 105(6):1165-1167. PubMed ID: 38777401
    [Abstract] [Full Text] [Related]

  • 15. Validation of Oxford Classification of Immunoglobulin A Nephropathy: an Iranian Experience.
    Sadeghipour A, Hendi A, Asgari M, Sotoudeh M, Parvin M, Filip I, Radfar A, Babaheidarian P.
    Iran J Kidney Dis; 2016 Jan 01; 10(1):17-21. PubMed ID: 26837676
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of the Oxford classification and the Oxford score in IgA nephropathy: A Tunisian study.
    Jebali H, Ghabi H, Mami I, Kaab BB, Fatma LB, Smaoui W, Haouet S, Mahjouba HB, Hassan M, Hmida FB, Raies L, Zouaghi MK.
    Saudi J Kidney Dis Transpl; 2020 Jan 01; 31(6):1366-1375. PubMed ID: 33565449
    [Abstract] [Full Text] [Related]

  • 17. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare.
    Hisano S, Joh K, Katafuchi R, Shimizu A, Hashiguchi N, Kawamura T, Matsuo S, IgA Nephropathy Study Group in Japan.
    Clin Exp Nephrol; 2017 Feb 01; 21(1):92-96. PubMed ID: 27011013
    [Abstract] [Full Text] [Related]

  • 18. The MEST score provides earlier risk prediction in lgA nephropathy.
    Barbour SJ, Espino-Hernandez G, Reich HN, Coppo R, Roberts IS, Feehally J, Herzenberg AM, Cattran DC, Oxford Derivation, North American Validation and VALIGA Consortia, Oxford Derivation North American Validation and VALIGA Consortia.
    Kidney Int; 2016 Jan 01; 89(1):167-75. PubMed ID: 26759049
    [Abstract] [Full Text] [Related]

  • 19. The Oxford classification of IgA nephropathy: single centre experience.
    Grcevska L, Ristovska V, Nikolov V, Petrusevska G, Milovanceva-Popovska M, Polenakovic M.
    Prilozi; 2010 Jan 01; 31(2):7-16. PubMed ID: 21258273
    [Abstract] [Full Text] [Related]

  • 20. Validation study of Oxford Classification of IgA Nephropathy: the significance of extracapillary hypercellularity and mesangial IgG immunostaining.
    Ştefan G, Ismail G, Stancu S, Zugravu A, Andronesi A, Mandache E, Mircescu G.
    Pathol Int; 2016 Aug 01; 66(8):453-9. PubMed ID: 27439692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.